The roche elecsys and siemens-centaur thyroglobulin autoantibody assays show comparable clinical performance to the recently unavailable beckman-coulter access thyroglobulin autoantibody assay in identifying samples with potentially false-low thyroglobulin measurements due to thyroglobulin autoantibody interference

Thyroid

Volumn 21, Issue 7, 2011, Pages 813-814

  Algeciras Schimnich, Alicia ^a   Lasho, Michael A ^a   Ness, Karl M ^a   Cheryk, Lynn A ^a   Grebe, Stefan K G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; THYROGLOBULIN; THYROGLOBULIN AUTOANTIBODY; UNCLASSIFIED DRUG;

ANALYZER; AUTOIMMUNE THYROIDITIS; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LETTER; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER;

AREA UNDER CURVE; AUTOANALYSIS; AUTOANTIBODIES; FALSE NEGATIVE REACTIONS; HUMANS; THYROGLOBULIN;

EID: 79959848113     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0158     Document Type: Letter

References (4)

1. Grebe SKG 2009 Diagnosis and management of thyroid carcinoma: a focus on serum thyroglobulin. Expert Rev Endocrinol Metab 4:25-43.
2. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS 2005 Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 90:5566-5575. (Pubitemid 41415459)
3. La'ulu SL, Slev PR, Roberts WL 2007 Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assays. Clin Chimica Acta 376:88-95. (Pubitemid 44880984)
4. Spencer C, Petrovic I, Fatemi S 2011 Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 96:1283-1291.